SCHEMBL370847

SCHEMBL370847

COc1ccc(Cn2cc(-c3nc(Nc4nsc(C)n4)sc3C#N)cn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.41
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
CYP19A1 P11511 2/20 0.36
ACHE P22303 3/20 0.35
RET P07949 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PGK1 P00558 1/20 0.34
JAK2 O60674 2/20 0.34
JAK1 P23458 2/20 0.34
TYK2 P29597 2/20 0.34
STAT3 P40763 2/20 0.34
JAK3 P52333 2/20 0.34
MAPT P10636 1/20 0.33
KLKB1 P03952 1/20 0.33
KDR P35968 2/20 0.33
ABL1 P00519 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3357349 0.81 NPC1 (0.43) NPC1ADORA2AADORA2BADORA1CYP19A1
SCHEMBL369473 0.79 NPC1 (0.42) NPC1ADORA2AADORA2BADORA1CYP19A1
SCHEMBL369020 0.79 MYC (0.43) NPC1ADORA2AADORA2BADORA1CYP19A1
SCHEMBL2528317 0.75 GRM4 (0.38) NPC1ADORA2AADORA2BADORA1CYP19A1
SCHEMBL2509685 0.73 ADORA2A (0.41) ADORA2AADORA2BADORA1CYP19A1ACHE
SCHEMBL370666 0.73 GRM4 (0.43) NPC1ADORA2AADORA2BADORA1ACHE
SCHEMBL1051726 0.71 CYP11B1 (0.41) NPC1ADORA2AADORA2BADORA1CYP19A1
SCHEMBL370318 0.71 GRM4 (0.47) AURKB
SCHEMBL368791 0.71 GRM4 (0.41) NPC1ADORA2AADORA2BADORA1ACHE
SCHEMBL2504661 0.70 GRM4 (0.41) NPC1ADORA2AADORA2BADORA1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US disclosed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM2, GRM4, GRM1 NPC1 1289/4885ADORA2A 81/4885ADORA2B 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.